Advancing deep learning-based segmentation for multiple lung cancer lesions in real-world multicenter CT scans.
Authors
Affiliations (5)
Affiliations (5)
- Research and Frontiers AI, Quibim, Valencia, Spain. [email protected].
- Research and Frontiers AI, Quibim, Valencia, Spain.
- Radiology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
- Biomedical Imaging Research Group (GIBI230) La Fe Health Research Institute, Valencia, Spain.
- Diagnostic Imaging Unit, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Abstract
Accurate segmentation of lung cancer lesions in computed tomography (CT) is essential for precise diagnosis, personalized therapy planning, and treatment response assessment. While automatic segmentation of the primary lung lesion has been widely studied, the ability to segment multiple lesions per patient remains underexplored. In this study, we address this gap by introducing a novel, automated approach for multi-instance segmentation of lung cancer lesions, leveraging a heterogeneous cohort with real-world multicenter data. We analyzed 1,081 retrospectively collected CT scans with 5,322 annotated lesions (4.92 ± 13.05 lesions per scan). The cohort was stratified into training (n = 868) and testing (n = 213) subsets. We developed an automated three-step pipeline, including thoracic bounding box extraction, multi-instance lesion segmentation, and false positive reduction via a novel multiscale cascade classifier to filter spurious and non-lesion candidates. On the independent test set, our method achieved a Dice similarity coefficient of 76% for segmentation and a lesion detection sensitivity of 85%. When evaluated on an external dataset of 188 real-world cases, it achieved a Dice similarity coefficient of 73%, and a lesion detection sensitivity of 85%. Our approach accurately detected and segmented multiple lung cancer lesions per patient on CT scans, demonstrating robustness across an independent test set and an external real-world dataset. AI-driven segmentation comprehensively captures lesion burden, enhancing lung cancer assessment and disease monitoring KEY POINTS: Automatic multi-instance lung cancer lesion segmentation is underexplored yet crucial for disease assessment. Developed a deep learning-based segmentation pipeline trained on multi-center real-world data, which reached 85% sensitivity at external validation. Thoracic bounding box and false positive reduction techniques improved the pipeline's segmentation performance.